India's No.1 Weekly For The Pharmaceutical Industry
About us || Feedback|| Advertising || Subscribe || Archives / Search 

Issue dated - 06th February 2003

Home > Corporate

Ranbaxy charts out multi-pronged strategy to boost NDDR
RANBAXY Laboratories while undertaking the planned expansion of the R&D facility is looking at employing all available tools to invigorate its new drug discovery research (NDDR) kitty.

Natco Pharma launches generic imatinib
NATCO Pharma Ltd here has launched an anti-cancer drug under the brand Veenat (Imatinib 100 mg capsules).

Indoco’s Verna factory gets UK-MCA nod
The Verna-Goa based solid dosage facility of Indoco Remedies Limited has received the UK-MCA certification.

Micro Labs all set to enter regulated markets
The Rs 20 crore formulations plant of the Bangalore based pharma major Micro Labs which is in final stages of completion, is expecting UKMCA approval as part of its first initiative to foray into the regulated markets.

Q3 Results

  
INSIDE PHARMA
CORPORATE 
EDITORIAL 
OPED 
TECHNOLOGY TRENDZ 
BULK DRUG TRENDS 
MARKET PLACE 
PRODUCTS 
CONVERSATION 
RESEARCH 
FAQ's 


Advanced Search
ARCHIVES
SUBSCRIBE
CUSTOMER SERVICE
CONTACT US
ADVERTISE
ABOUT US

 Network Sites

  Express Computer

  IT People
  Network Magazine
  Business Traveller
  Hotelier & Caterer
  Travel & Tourism
  Exp. Backwaters
  Healthcare Mgmt.
  Express Textile
 Group Sites
  ExpressIndia
  Indian Express
  Financial Express

<Top of page>
ABOUT US FEEDBACK ADVERTISE SUBSCRIBE ARCHIVES
 


© Copyright 2000: Indian Express Group (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by
The Business Publications Division of the Indian Express Group of Newspapers. Please contact our Webmaster for any queries on this site.